#KnowBeforeYouInvest

MC Technicals

Trend

i

This represents current trend.Click here for disclaimer.

Industry Comparison

    Others

      Open83.25
      Previous Close83.15
      Volume756,889.00
      Value (Lacs)646.38
      i  VWAP 85.75
      Beta1.010.95
      High87.85
      Low82.95
      UC Limit99.75
      LC Limit66.55
      52 Week High116.00
      52 Week Low43.95
      TTM EPS-7.92
      TTM PE--
      Sector PE39.82
      Book Value Per Share5.58
      P/B15.31
      Face Value1.00
      Mkt Cap (Rs. Cr.)1,087
      Dividend Yield0.00
      20D Avg Volume801,364
      20D Avg Delivery(%)31.59

      Advanced Chart

      Click here to expand

      *Delayed by 20 seconds.

      MC Insights

      Stock not eligible for rating

      Get detailed analysis with Moneycontrol Stock Insights.

      Get detailed analysis with Moneycontrol Stock Insights.

      Price

      • Mid Range Momentum - Stock is Mid Range compared to Short, Medium and Long Term Moving Averages

      Industry Comparison

      • TTM PE Ratio - Negative PE TTM

      Shareholding Pattern

      • Promoters holding remains unchanged at 60.0% in Jun 2021 qtr
      • Investor Presentation
      • Earnings Transcripts
      • FDA Warnings
      • Credit Rating
      • Resignation

      MC Technicals

      TECHNICAL RATING

      i

      This represents current trend.
      Click here for disclaimer.

      Moving Averages --
      Technical Indicators --
      Moving Averages Crossovers --

      Pivot levels

      Type R1 R2 R3 PP S1 S2 S3
      Classic - - - - - - - - - - - - - -
      Fibonacci - - - - - - - - - - - - - -
      Camarilla - - - - - - - - - - - - - -

      Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

      Pivot levels

      R1 - - Pivot
      - -
      S1 - -
      R2 - - S2 - -
      R3 - - S3 - -

      Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

      Moving Averages

      Days
      5 - -
      10 - -
      20 - -
      50 - -
      100 - -
      200 - -

      TECHNICAL RATING

      i

      This represents current trend.
      Click here for disclaimer.

      Moving Averages --
      Technical Indicators --
      Moving Averages Crossovers --

      Pivot levels

      Type R1 R2 R3 PP S1 S2 S3
      Classic - - - - - - - - - - - - - -
      Fibonacci - - - - - - - - - - - - - -
      Camarilla - - - - - - - - - - - - - -

      Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

      Pivot levels

      R1 - - Pivot
      - -
      S1 - -
      R2 - - S2 - -
      R3 - - S3 - -

      Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

      TECHNICAL RATING

      i

      This represents current trend.
      Click here for disclaimer.

      Moving Averages --
      Technical Indicators --
      Moving Averages Crossovers --

      Pivot levels

      Type R1 R2 R3 PP S1 S2 S3
      Classic - - - - - - - - - - - - - -
      Fibonacci - - - - - - - - - - - - - -
      Camarilla - - - - - - - - - - - - - -

      Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

      Pivot levels

      R1 - - Pivot
      - -
      S1 - -
      R2 - - S2 - -
      R3 - - S3 - -

      Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

      Price and Volume

      Price Performance

      1 Week --%
      1 Month --%
      3 Months --%
      YTD --%
      1 Year --%
      3 Years --%

      Forum

      Community Sentiments

      • 100% BUY
      • 0% SELL
      • 0% HOLD

      100%

      of moneycontrol users recommend buying Suven Life Sci

      Broker Research

      No Data For Broker Research.

      Deals

      *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

      GRAVITON RESEARCH CAPITAL LLP

      Qty 640960 Price 109.64 % Traded 0.50

      GRAVITON RESEARCH CAPITAL LLP

      Qty 640960 Price 109.97 % Traded 0.50

      ALPHA LEON ENTERPRISES LLP

      Qty 656474 Price 104.94 % Traded 0.52

      ALPHA LEON ENTERPRISES LLP

      Qty 627462 Price 105.08 % Traded 0.49

      KATKAR SANJAY

      Qty 688893 Price 56.27 % Traded 0.54

      ALPHA LEON ENTERPRISES LLP

      Qty 750015 Price 29.75 % Traded 0.59

      ALPHA LEON ENTERPRISES LLP

      Qty 761598 Price 32.17 % Traded 0.60

      ALPHA LEON ENTERPRISES LLP

      Qty 744288 Price 24.86 % Traded 0.58

      *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

      Insider Transaction Summary

      Jasti Property and Equity Holdings Private Limited (in its capacity as sole trustee of the Jasti Family Trust)

      Promoter Group

      Qty 18100000 Price 81.57 % Traded 14.22 Post Tnx Hold. 4.98%

      VENKATA RAMUDU JASTHI

      Directors Immediate Relative

      Qty 15000 Price 49.3 % Traded 0.01 Post Tnx Hold. 0.05%

      VENKATA RAMUDU JASTHI

      Directors Immediate Relative

      Qty 10000 Price 53.81 % Traded 0.01 Post Tnx Hold. 0.04%

      VENKATA RAMUDU JASTHI

      Directors Immediate Relative

      Qty 20000 Price 52.72 % Traded 0.02 Post Tnx Hold. 0.03%

      VENKATA RAMUDU JASTHI

      Directors Immediate Relative

      Qty 20000 Price 50.01 % Traded 0.02 Post Tnx Hold. 0.02%

      Jasti Property and Equity Holdings Pvt Ltd

      Promoter

      Qty 550000 Price 195.99 % Traded 0.43 Post Tnx Hold. 60%

      *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

      Jasti Property and Equity Holdigns Pvt Ltd & PACs

      Promoter

      Qty 0 Price 0 % Traded 0.00 Post Tnx Hold. 60%

      Jasti Property and Equity Holdigns Pvt Ltd Acquisition

      Promoter

      Qty 550000 Price 0 % Traded 0.43 Post Tnx Hold. 60%

      Jasti Property & Equity Holdings Pvt Ltd Acquisition

      Promoter

      Qty 162424 Price 0 % Traded 0.13 Post Tnx Hold. 59.57%

      Jasti Property & Equity Holdings Pvt Ltd Acquisition

      Other

      Qty 75652576 Price 0 % Traded 59.44 Post Tnx Hold. 0%

      Jasti Property & Equity Holdings Pvt Ltd Acquisition

      Promoter

      Qty 75652576 Price 0 % Traded 59.44 Post Tnx Hold. 59.44%

      Subba Rao Jasti Disposal

      Promoter

      Qty 75652576 Price 0 % Traded 59.44 Post Tnx Hold. 0%

      *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

      Corporate Action

      Ex-Date Type Dividend (Rs)
      Announcement Date Ex-Bonus Ratio

      PEERS

      Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
      Suven Life Sci 85.40 2.71 1,086.99 - 15.30 -66.80 75.54 -72 13 0.00
      Sun Pharma 788.50 -0.70 189,187.56 31.40 3.82 6.24 51.21 2,284 33,498 0.07
      Divis Labs 5,202.65 0.56 138,114.01 67.39 14.86 21.34 61.02 1,984 6,969 0.00
      Dr Reddys Labs 4,763.45 1.26 79,253.99 45.62 4.49 11.06 9.46 1,903 19,047 0.17
      Cipla 922.85 -2.63 74,441.80 29.29 4.01 13.12 25.29 2,401 19,159 0.08

      About the Company

      Suven Life Sciences Ltd is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.The different business units of the company includes C.R.A.M.S-The companys main thrust is in Contract Research and Manufacturing Services (C-R-A-M-S). Suven`s C-R-A-M-S serves as many as 22 global Life Science and Fine Chemical Companies by developing and supplying cost effective Pharmaceutical and Agro Chemical Intermediates for New Chemical Entities (NCE`s).DDDSS-Drug Discovery & Development Support Services (DDDSS) aims to provide Contract Drug Discovery & Development services in Medicinal chemistry, Process chemistry, Analytical chemistry, In-vitroScreening, DMPK, Brain Microdialysis, CV Safety, In-vivo Metabolic Disorders & CNS Pharmacology, Phase-I Bio-analysis and Discovery Toxicology.The product range of the company includes Advanced Intermediates,IntermediatesActive,Pharmaceutical Ingredients (APIs ) and Stock Chemicals for Disposal..The company also in the business segment of Services (DDDSS), Manufacturing (CRAMS).

      • Registered Office

      • Registrars

        • Address

          Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

        • City

          Hyderabad 500032

        • State

          Telangana

        • Tel. No.

          040-67161500, 67162222, 33211000

        • Fax No.

          040-23420814, 23001153

        • Email

          einward.ris@karvy.com

        • Internet

          http://www.kfintech.com

      • Management

        • Venkateswarlu Jasti

          Chairman & CEO

        • Sudharani Jasti

          Whole Time Director

        • J A S Padmaja

          Director

        • Seyed E Hasnain

          Director

        • M Gopalakrishna

          Director

      • Included In

        • BSE 100

          No

        • BSE 200

          No

        • SENSEX

          No

        • CNX MIDCAP 200

          No

        • NIFTY 50

          No

        • BSE 500

          No

      • Details

        • BSE:

          530239

        • NSE:

          SUVEN

        • Series

          EQ

        • ISIN

          INE495B01038

      Contact us

      Find us at the office

      Trailor- Verkamp street no. 63, 81415 Zagreb, Croatia

      Give us a ring

      Dezha Manci
      +38 695 645 231
      Mon - Fri, 8:00-22:00

      Reach out